| Position | Action |
|---|---|
| Price reaches $185 | Scale out 1/3 position |
| Price reaches $192 | Scale out another 1/3 position |
| Price reaches $204 | Hold final 1/3 for structural test of 200 SMA |
| Daily close below $170 | Hard stop — exit entire position |
| Post-Q2 FY27 earnings | Reassess sizing based on results |
CRM is a category-leading, cash-generating SaaS franchise trading at a 34% discount to fair value with confirmed technical reversal signals and multiple bullish catalysts converging into Q2 earnings.
| Indicator | Value | Signal |
|---|---|---|
| Close | $180.71 | — |
| 10 EMA | 174.41 | bullish |
| 50 SMA | 170.78 | bullish |
| 200 SMA | 204.48 | bearish |
| RSI (14) | 57.83 | neutral |
| MACD | +3.06 | bullish |
| MACD Signal | +0.88 | bullish |
| MACD Histogram | +2.19 | bullish |
| Bollinger Upper | 184.54 | neutral |
| Bollinger Middle | 169.73 | bullish |
| Bollinger Lower | 154.92 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain neutral CRM exposure; scale out into strength, not into volatility
The HOLD consensus is most defensible given genuinely balanced evidence. The aggressive bull case — elite $16.5B TTM FCF (11% unlevered yield, 12x interest coverage), confirmed 10/50 EMA golden cross, MACD bullish flip, RSI recovery from 29.97 to 57.83 — supports maintaining exposure but does not justify adding at current levels. The conservative bear concerns are valid: FCF seasonality (Q1 FY27's $6.5B vs Q2 FY26's $605M flatters the headline figure), $25B debt load's full-year interest burden (~$1B+ annually) not yet in trailing metrics, gross margin compression from 78% to 60% post-Informatica as a multi-year integration outcome rather than one-time noise, and the July 30 -4% drop on a market rally day indicating genuine relative weakness. The "bear case is priced in" framing is dangerous — the 44% drawdown reflects market belief three weeks ago, not a static floor; the June 22 capitulation low at $146.32 is a real recent price that reactivates on Q2 disappointment. Scale modestly at $170-174 ONLY with RSI holding above 45, sized below full conviction, using the existing $170 stop as protection. Upgrade triggers: 200 SMA reclaim on volume >50M, cRPO beat >3pp, gross margin recovery above 70%, or confirmed dovish Fed pivot. Downgrade triggers: cRPO miss >2pp, vague Agentforce commentary, hawkish Fed surprise, or goodwill impairment disclosure on the $59.3B base. Price target revised to $242 (down from $248), implying 2-3:1 reward/risk rather than the aggressive analyst's claimed 6:1.
When: Current remaining performance obligation beats consensus by >3 percentage points
Then: Positive fundamental signal for addition
↩ rebuts: “Bear narrative of 'slower core growth'”
· concedes: A 2.6% fair value revision from $248.24 to $241.72 signals more realistic AI monetization timing; 200 SMA at $204.48 represents real overhead resistance requiring confirmation; Goodwill at 55% of assets and negative tangible book value are legitimate concerns for traditional valuation metrics; The stock fell 4% in a day while market rallied, though after a 14.5% four-session rally
Salesforce should be sold or underweighted because the apparent upside is built on debt-engineered EPS rather than organic growth, the technical bounce is counter-trend within an intact downtrend, and the macro environment is structurally hostile to high-multiple SaaS names, making the risk/reward asymmetric in favor of further downside.
· concedes: Sustained revenue growth at 12-14% is theoretically achievable if AI demand materializes; The stock is down 33% from highs, representing some correction already; Buyback does provide EPS support in the short term; ServiceNow is also down 25% YTD, suggesting sector-level issues not unique to CRM; A decisive Q2 beat with strong Agentforce ARR could reprice the stock significantly higher
→ vs conservative: Debt-to-equity of 124% mischaracterized as distress; coverage ratio of 12x and debt cost at <8% of cash generation indicates financial engineering, not leverage risk
→ vs conservative: Gross margin compression from 78% to 60% is one-time acquisition accounting noise from Informatica, not structural deterioration
→ vs conservative: Q2 earnings described as 'binary with downside higher probability' ignores that 44.5% drawdown already prices in disappointment, not potential disappointment
→ vs neutral: Waiting for confirmed close above $205 (14% rally) before adding is performance chasing disguised as discipline; fair value will be revised higher by then on Agentforce traction
→ vs neutral: The $200 SMA is a magnet, not a barrier; waiting for confirmation means buying at worse risk-reward once consensus catches up
→ vs neutral: Macro tape concerns and AI capex unwind misapplied to CRM which benefits from enterprise AI deployment, not AI infrastructure capex cycles
| 8.45 |
| neutral |
| VWMA | 171.90 | bullish |
Support: 174.41 · 170.78 · 154.92 | Resistance: 184.54 · 188.38 · 204.48
Salesforce (CRM) exhibits short-term bullish momentum with price above key fast moving averages (10 EMA and 50 SMA both reclaimed), RSI mid-range at 57.83, and MACD showing expanding positive histogram (+2.19). However, the 200 SMA at $204.48 represents major long-term resistance, the 50 SMA continues declining, and elevated ATR (8.45) signals ongoing volatility risk. The recommendation is HOLD with bullish tactical lean: existing holders should trail stops at the 10 EMA ($174.41), while new entries are best scaled on pullbacks to the $170–174 zone or confirmed closes above $188 with volume.
Market Cap
$148.0 billion
Share Price
~$180
P/E Ratio (TTM)
20.94x
Forward P/E
11.65x
PEG Ratio
0.78
Price-to-Book
4.32x
EV/EBITDA (implied)
~13.7x
50-Day Moving Average
$170.91
200-Day Moving Average
$205.68
Beta
1.178
Dividend Yield
0.97%
52-Week High
$269.11
52-Week Low
$146.32
TTM Revenue
$42.83 billion
Q1 FY27 Revenue (Apr-2026)
$11,133M
Q4 FY26 Revenue (Jan-2026)
$11,201M
Q3 FY26 Revenue (Oct-2025)
$10,259M
Q2 FY26 Revenue (Jul-2025)
$10,236M
Q1 FY26 Revenue (Apr-2025)
$9,829M
Q1 FY27 Gross Margin
~60%
Core Gross Margin (ex-acquisition)
~77-78%
Gross Profit
$33.25B
Operating Margin
21.8%
EBITDA
$12.89B
Net Income
$8.02B
Q1 FY27 Net Income
+$2.1B
Profit Margin
18.7%
ROE
16.9%
ROA
5.7%
EPS (TTM)
$8.63
Forward EPS
$15.51
Q1 FY26 EPS
$1.59
Q2 FY26 EPS
$1.96
Q3 FY26 EPS
$2.19
Q4 FY26 EPS
$2.07
Q1 FY27 EPS
$2.42
Q1 FY27 Total Assets
$106.68B
Q4 FY26 Total Assets
$112.31B
Q1 FY27 Total Debt
$41.88B
Q4 FY26 Total Debt
$17.18B
Q1 FY27 Net Debt
$30.35B
Q4 FY26 Net Debt
$7.11B
Q1 FY27 Stockholders' Equity
$34.24B
Q4 FY26 Stockholders' Equity
$59.14B
Q1 FY27 Treasury Stock
$55.03B
Q4 FY26 Treasury Stock
$32.23B
Q1 FY27 Cash & Equivalents
$8.94B
Q4 FY26 Cash & Equivalents
$7.33B
Q1 FY27 Goodwill
$59.29B
Q4 FY26 Goodwill
$57.94B
Q1 FY27 Working Capital
-$5.89B
Q4 FY26 Working Capital
-$8.90B
Q1 FY27 Current Ratio
0.79
Q4 FY26 Current Ratio
0.76
Q1 FY27 Share Buyback
$27.25 billion
Q1 FY27 New Debt Issuance
$24.84 billion
Q1 FY27 Business Acquisition
$1.45 billion
Debt/Equity
124.3%
Goodwill/Total Assets
55%
Tangible Book Value
-$31.7B
Q1 FY27 Share Count
819M
Q1 FY27 Interest Expense
$317M
TTM Free Cash Flow
$16.55 billion
Q1 FY27 Operating Cash Flow
$6,701M
Q1 FY27 CapEx
$145M
Q1 FY27 Free Cash Flow
$6,556M
Q4 FY26 Free Cash Flow
$5,323M
Q3 FY26 Free Cash Flow
$2,177M
Q2 FY26 Free Cash Flow
$605M
Q1 FY26 Free Cash Flow
$6,297M
Annual CapEx
~$140-180M/quarter
Q1 FY27 Dividends Paid
$365M
Q4 FY26 Dividends Paid
$391M
Q3 FY26 Dividends Paid
$395M
Q2 FY26 Dividends Paid
$399M
Q1 FY26 Dividends Paid
$402M
Annual Dividend
$1.66/year ($0.415/quarter)
Current Deferred Revenue
$20.4B
Cash & Investments
$8.9B + $7.7B
Strengths
Concerns
Salesforce demonstrates a compelling value case with a P/E of 20.94x and PEG below 1.0, supported by elite $16.5B TTM free cash flow and best-in-class 77.6% gross margins, while revenue growth re-accelerates to ~13% YoY and EPS compounds at 52% YoY. However, a massive leveraged buyback in Q1 FY27 ($27.25B financed by $24.84B new debt) has materially deteriorated the balance sheet, pushing Debt/Equity to 124%, net debt to $30.35B, and tangible book value to negative $31.7B. The forward P/E of 11.65x embeds aggressive assumptions for AI/Agentforce-driven margin expansion, creating execution risk if monetization disappoints, while the elevated goodwill concentration (55% of assets) poses impairment risk.